BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4554497)

  • 1. Microsomal N-oxidation of dapson as a cause of methemoglobin formation in human red cells.
    Cucinell SA; Israili ZH; Dayton PG
    Am J Trop Med Hyg; 1972 May; 21(3):322-31. PubMed ID: 4554497
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of methemoglobin formation by diphenylsulfones. Effect of 4-amino-4'-hydroxyaminodiphenylsulfone and other p-substituted derivatives.
    Kramer PA; Glader BE; Li TK
    Biochem Pharmacol; 1972 May; 21(9):1265-74. PubMed ID: 5038672
    [No Abstract]   [Full Text] [Related]  

  • 3. N-hydroxylation of 4,4'-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans.
    Uehleke H; Tabarelli S
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):55-68. PubMed ID: 4145470
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Mar; 45(5):1027-33. PubMed ID: 8461032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the metabolism of dapsone in man and experimental animals: formation of N-hydroxy metabolites.
    Israili ZH; Cucinell SA; Vaught J; Davis E; Lesser JM; Dayton PG
    J Pharmacol Exp Ther; 1973 Oct; 187(1):138-51. PubMed ID: 4583459
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of the mononitro derivative of dapsone as a product from an oxidation in vitro.
    Tyler TR; Buhs RP; VandenHuevel WJ
    Biochem Pharmacol; 1973 Jun; 22(11):1383-5. PubMed ID: 4727788
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Oct; 46(8):1363-8. PubMed ID: 8240384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450-dependent toxicity of dapsone in human erythrocytes.
    Ganesan S; Sahu R; Walker LA; Tekwani BL
    J Appl Toxicol; 2010 Apr; 30(3):271-5. PubMed ID: 19998329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1990 Dec; 30(6):829-38. PubMed ID: 2288829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1991 Jul; 32(1):120-3. PubMed ID: 1888631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic side-effects of dapsone.
    Wilson JR; Harris JW
    Ohio State Med J; 1977 Aug; 73(8):557-60. PubMed ID: 887243
    [No Abstract]   [Full Text] [Related]  

  • 12. Proposed mechanism of nitrite-induced methemoglobinemia.
    Titov VY; Petrenko YM
    Biochemistry (Mosc); 2005 Apr; 70(4):473-83. PubMed ID: 15892615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxidation of the antimalarial drug primaquine: characterization of a benzidine-like metabolite with methaemoglobin-forming activity.
    Morais Mda S; Augusto O
    Xenobiotica; 1993 Feb; 23(2):133-9. PubMed ID: 8498077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methemoglobin formation and glutathione disappearance in cord blood red cells exposed to acetylphenylhydrazine.
    Etukudo MH; Ramachandran M; Iyer GY
    Clin Chim Acta; 1984 Apr; 138(2):135-9. PubMed ID: 6723057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methemoglobin pathophysiology.
    Jaffé ER
    Prog Clin Biol Res; 1981; 51():133-51. PubMed ID: 7022466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-hydroxylation of 4,4'-diaminodiphenylsulphone in liver microsomes and in vivo.
    Tabarelli S; Uehleke H
    Xenobiotica; 1971; 1(4):501-2. PubMed ID: 4152967
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. IV: Implications for the development of agranulocytosis.
    Coleman MD; Simpson J; Jacobus DP
    Biochem Pharmacol; 1994 Oct; 48(7):1349-54. PubMed ID: 7945432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro.
    Coleman MD; Tingle MD; Hussain F; Storr RC; Park BK
    J Pharm Pharmacol; 1991 Nov; 43(11):779-84. PubMed ID: 1686906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrosobenzene-induced ferrihemoglobin formation in Japanese quail erythrocytes. The significance of ferrihemoglobin reduction.
    Blaauboer BJ; van Holsteijn CW; Wit JG
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(2):127-35. PubMed ID: 1165790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of NO-induced methemoglobinemia requires extremely high doses of ascorbic acid in vitro.
    Dötsch J; Demirakça S; Cryer A; Hänze J; Kühl PG; Rascher W
    Intensive Care Med; 1998 Jun; 24(6):612-5. PubMed ID: 9681784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.